Collegium Pharmaceutical, Inc. (COLL)
24.72
+0.51
(+2.11%)
USD |
NASDAQ |
Nov 09, 09:59
Collegium Pharmaceutical Market Cap : 803.36M for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 786.78M |
| November 05, 2026 | 817.66M |
| November 04, 2026 | 769.23M |
| November 03, 2026 | 771.18M |
| November 02, 2026 | 769.56M |
| October 30, 2026 | 773.46M |
| October 29, 2026 | 780.93M |
| October 28, 2026 | 754.94M |
| October 27, 2026 | 747.46M |
| October 26, 2026 | 754.29M |
| October 23, 2026 | 746.16M |
| October 22, 2026 | 763.71M |
| October 21, 2026 | 744.70M |
| October 20, 2026 | 754.94M |
| October 19, 2026 | 747.79M |
| October 16, 2026 | 753.64M |
| October 15, 2026 | 753.31M |
| October 14, 2026 | 731.54M |
| October 13, 2026 | 699.69M |
| October 12, 2026 | 716.59M |
| October 09, 2026 | 717.89M |
| October 08, 2026 | 718.54M |
| October 07, 2026 | 712.69M |
| October 06, 2026 | 711.06M |
| October 05, 2026 | 710.74M |
| Date | Value |
|---|---|
| October 02, 2026 | 715.61M |
| October 01, 2026 | 709.76M |
| September 30, 2026 | 709.11M |
| September 29, 2026 | 722.44M |
| September 28, 2026 | 735.44M |
| September 25, 2026 | 732.19M |
| September 24, 2026 | 735.76M |
| September 23, 2026 | 729.59M |
| September 22, 2026 | 740.31M |
| September 21, 2026 | 748.76M |
| September 18, 2026 | 739.99M |
| September 17, 2026 | 727.31M |
| September 16, 2026 | 721.14M |
| September 15, 2026 | 709.76M |
| September 14, 2026 | 741.29M |
| September 11, 2026 | 739.34M |
| September 10, 2026 | 744.86M |
| September 09, 2026 | 759.16M |
| September 08, 2026 | 759.49M |
| September 04, 2026 | 764.68M |
| September 03, 2026 | 770.21M |
| September 02, 2026 | 789.71M |
| September 01, 2026 | 779.96M |
| August 31, 2026 | 799.78M |
| August 28, 2026 | 823.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.551B |
| Corcept Therapeutics, Inc. | 7.891B |
| Veru, Inc. | 37.34M |
| Johnson & Johnson | 668.50B |
| Eli Lilly & Co. | 1.311T |
Market Cap Related Metrics
| PE Ratio | 24.93 |
| PS Ratio | 1.150 |
| Price to Book Value | 2.591 |
| Price to Free Cash Flow | 2.788 |
| Price | 24.72 |
| Earnings Yield | 4.01% |
| Operating PE Ratio | 7.456 |
| Normalized PE Ratio | 18.89 |